Weekly Digest – 13-19 May 2023 Weekly Digest – 13-19 May 2023 May 18, 2023: Repotrectinib (IV) / ROS1-positive NSCLC / Zai lab: Received Priority Review from China NMPA Center for Drug Evaluation (CDE) of China’s NMPA granted priority review […]
Weekly Digest – 13-19 May 2023 Weekly Digest – 13-19 May 2023 May 17, 2023: Rivoceranib / Camrelizumab / Unresectable HCC / Elevar Therapeutics: Submitted a New Drug Application to FDA Elevar Therapeutics submitted NDA to the FDA based on […]
Weekly Digest – 13-19 May 2023 Weekly Digest – 13-19 May 2023 May 17, 2023: TAGRISSO (Osimertinib) (IV) / EGFRm NSCLC / AstraZeneca: Positive data from Phase 3 FLAURA2 study AstraZeneca reported positive topline data from, the Phase 3 FLAURA2 […]
Weekly Digest – 13-19 May 2023 Weekly Digest – 13-19 May 2023 May 15, 2023: IMPT-314 (IV) / R/R Aggressive B Cell Lymphoma / ImmPACT Bio: Received Fast Track Designation FDA granted a Fast Track Designation for IMPT-314 a potential […]
Weekly Digest – 13-19 May 2023 Weekly Digest – 13-19 May 2023 May 15, 2023: HMBD-001 / SqNSCLC / Hummingbird Bioscience / Merck: Announced a clinical trial collaboration Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck […]
Weekly Digest – 13-19 May 2023 Weekly Digest – 13-19 May 2023 May 15, 2023: IBI351 (IV) / Colorectal Cancer / Innovent Bio: Received China NMPA Breakthrough Designation China NMPA granted Breakthrough Designation (BTD) for IBI351 for the treatment of […]
